Annual Accounts Payable
$2.68 M
+$554.00 K+26.11%
December 31, 2023
Summary
- As of March 13, 2025, ANTX annual accounts payable is $2.68 million, with the most recent change of +$554.00 thousand (+26.11%) on December 31, 2023.
- During the last 3 years, ANTX annual accounts payable has risen by +$2.54 million (+1927.27%).
- ANTX annual accounts payable is now at all-time high.
Performance
ANTX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.71 M
-$174.00 K-9.23%
September 30, 2024
Summary
- As of March 13, 2025, ANTX quarterly accounts payable is $1.71 million, with the most recent change of -$174.00 thousand (-9.23%) on September 30, 2024.
- Over the past year, ANTX quarterly accounts payable has dropped by -$722.00 thousand (-29.68%).
- ANTX quarterly accounts payable is now -64.92% below its all-time high of $4.88 million, reached on September 30, 2023.
Performance
ANTX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
ANTX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +26.1% | -29.7% |
| 3 y3 years | +1927.3% | -29.7% |
| 5 y5 years | +1927.3% | -29.7% |
ANTX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +151.7% | -64.9% | +61.0% |
| 5 y | 5-year | at high | +1927.3% | -64.9% | +61.0% |
| alltime | all time | at high | +1927.3% | -64.9% | +61.0% |
AN2 Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.71 M(-9.2%) |
| Jun 2024 | - | $1.89 M(-22.5%) |
| Mar 2024 | - | $2.43 M(-9.1%) |
| Dec 2023 | $2.68 M(+26.1%) | $2.68 M(-45.1%) |
| Sep 2023 | - | $4.88 M(+55.8%) |
| Jun 2023 | - | $3.13 M(-11.7%) |
| Mar 2023 | - | $3.54 M(+67.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $2.12 M(+99.6%) | $2.12 M(+47.4%) |
| Sep 2022 | - | $1.44 M(-10.7%) |
| Jun 2022 | - | $1.61 M(-38.2%) |
| Mar 2022 | - | $2.61 M(+145.4%) |
| Dec 2021 | $1.06 M(+705.3%) | - |
| Dec 2021 | - | $1.06 M |
| Dec 2020 | $132.00 K | - |
FAQ
- What is AN2 Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for AN2 Therapeutics?
- What is AN2 Therapeutics annual accounts payable year-on-year change?
- What is AN2 Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for AN2 Therapeutics?
- What is AN2 Therapeutics quarterly accounts payable year-on-year change?
What is AN2 Therapeutics annual accounts payable?
The current annual accounts payable of ANTX is $2.68 M
What is the all time high annual accounts payable for AN2 Therapeutics?
AN2 Therapeutics all-time high annual accounts payable is $2.68 M
What is AN2 Therapeutics annual accounts payable year-on-year change?
Over the past year, ANTX annual accounts payable has changed by +$554.00 K (+26.11%)
What is AN2 Therapeutics quarterly accounts payable?
The current quarterly accounts payable of ANTX is $1.71 M
What is the all time high quarterly accounts payable for AN2 Therapeutics?
AN2 Therapeutics all-time high quarterly accounts payable is $4.88 M
What is AN2 Therapeutics quarterly accounts payable year-on-year change?
Over the past year, ANTX quarterly accounts payable has changed by -$722.00 K (-29.68%)